158 related articles for article (PubMed ID: 7907060)
1. Prognostic significance of ureteral obstruction in primary cervical cancer.
Lee SK; Jones HW
Int J Gynaecol Obstet; 1994 Jan; 44(1):59-65. PubMed ID: 7907060
[TBL] [Abstract][Full Text] [Related]
2. Survival and quality of life after percutaneous nephrostomy for malignant ureteric obstruction in patients with terminal cervical cancer.
Emmert C; Rassler J; Köhler U
Arch Gynecol Obstet; 1997; 259(3):147-51. PubMed ID: 9187468
[TBL] [Abstract][Full Text] [Related]
3. Factors Affecting Survival Outcome After Percutaneous Nephrostomy as Palliative Urinary Diversion in Obstructive Uropathy due to Advance Cervical Cancer Patients.
Noegroho BS; Kurniawan AP; Wijayanti Z; Mustafa A
Asian Pac J Cancer Prev; 2021 Apr; 22(4):1211-1216. PubMed ID: 33906314
[TBL] [Abstract][Full Text] [Related]
4. Prognostic model for predicting survival after palliative urinary diversion for ureteral obstruction: analysis of 140 cases.
Ishioka J; Kageyama Y; Inoue M; Higashi Y; Kihara K
J Urol; 2008 Aug; 180(2):618-21; discussion 621. PubMed ID: 18554655
[TBL] [Abstract][Full Text] [Related]
5. Clinical outcome and management of ureteral obstruction secondary to gastric cancer.
Migita K; Watanabe A; Samma S; Ohyama T; Ishikawa H; Kagebayashi Y
World J Surg; 2011 May; 35(5):1035-41. PubMed ID: 21387134
[TBL] [Abstract][Full Text] [Related]
6. Percutaneous nephrostomy and ureteral stenting in gynecologic malignancies.
Barton DP; Morse SS; Fiorica JV; Hoffman MS; Roberts WS; Cavanagh D
Obstet Gynecol; 1992 Nov; 80(5):805-11. PubMed ID: 1407920
[TBL] [Abstract][Full Text] [Related]
7. Palliative percutaneous and endoscopic urinary diversion for malignant ureteral obstruction.
Gasparini M; Carroll P; Stoller M
Urology; 1991 Nov; 38(5):408-12. PubMed ID: 1719688
[TBL] [Abstract][Full Text] [Related]
8. Palliative urinary diversion in carcinoma of the cervix.
Meyer JE; Green TH; Yatsuhashi M
Obstet Gynecol; 1980 Jan; 55(1):95-8. PubMed ID: 6153241
[TBL] [Abstract][Full Text] [Related]
9. Management of extrinsic malignant ureteral obstruction with urinary diversion.
Kanou T; Fujiyama C; Nishimura K; Tokuda Y; Uozumi J; Masaki Z
Int J Urol; 2007 Aug; 14(8):689-92. PubMed ID: 17681056
[TBL] [Abstract][Full Text] [Related]
10. Clinical Outcomes After Urinary Diversion for Malignant Ureteral Obstruction Secondary to Non-urologic Cancer: An Analysis of 778 Cases.
Heo JE; Jeon DY; Lee J; Ham WS; Choi YD; Jang WS
Ann Surg Oncol; 2021 Apr; 28(4):2367-2373. PubMed ID: 33389298
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of locally advanced cervical cancer presenting with obstructive uropathy: An institutional audit.
Salunkhe R; Chopra S; Kulkarni S; Shetty N; Engineer R; Mahantshetty U; Ghosh J; Gupta S; Shrivastava SK
Indian J Cancer; 2020; 57(4):416-422. PubMed ID: 33078748
[TBL] [Abstract][Full Text] [Related]
12. Percutaneous nephrostomy in gynecologic oncology patients.
Soper JT; Blaszczyk TM; Oke E; Clarke-Pearson D; Creasman WT
Am J Obstet Gynecol; 1988 May; 158(5):1126-31. PubMed ID: 2453117
[TBL] [Abstract][Full Text] [Related]
13. Nonoperative urinary diversion for malignant ureteral obstruction.
Zadra JA; Jewett MA; Keresteci AG; Rankin JT; St Louis E; Grey RR; Pereira JJ
Cancer; 1987 Sep; 60(6):1353-7. PubMed ID: 3621117
[TBL] [Abstract][Full Text] [Related]
14. Percutaneous nephrostomy in the management of malignant ureteral obstruction secondary to bladder cancer.
Ekici S; Sahin A; Ozen H
J Endourol; 2001 Oct; 15(8):827-9. PubMed ID: 11724123
[TBL] [Abstract][Full Text] [Related]
15. Survival Outcome of Urinary Diversion in Advanced Cervical Cancer Patients with Hydronephrosis.
Dhani FK; Daryanto B; Seputra KP
Asian Pac J Cancer Prev; 2023 Aug; 24(8):2641-2646. PubMed ID: 37642049
[TBL] [Abstract][Full Text] [Related]
16. Operative retroperitoneal ureteral catheterization for obstructive uropathy in primary locally advanced carcinoma of the cervix: description of a technique and experience.
Rose PG
Gynecol Oncol; 1996 Apr; 61(1):79-82. PubMed ID: 8626122
[TBL] [Abstract][Full Text] [Related]
17. Long-term results of metallic stents for malignant ureteral obstruction in advanced cervical carcinoma.
Lang EK; Winer AG; Abbey-Mensah G; Anne R; Allaei A; Friedman F; Thomas R; La Nasa J; Davis R
J Endourol; 2013 May; 27(5):646-51. PubMed ID: 23199302
[TBL] [Abstract][Full Text] [Related]
18. A prognostic model for survival after palliative urinary diversion for malignant ureteric obstruction: a prospective study of 208 patients.
Cordeiro MD; Coelho RF; Chade DC; Pessoa RR; Chaib MS; Colombo-Júnior JR; Pontes-Júnior J; Guglielmetti GB; Srougi M
BJU Int; 2016 Feb; 117(2):266-71. PubMed ID: 25327474
[TBL] [Abstract][Full Text] [Related]
19. Palliative urinary diversion in patients with advanced cervical cancer.
Fukuoka M; Suzuki A; Fujii S; Okamura H
Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):293-8. PubMed ID: 6201402
[TBL] [Abstract][Full Text] [Related]
20. The management of malignant ureteral obstruction treated with ureteral stents.
Ganatra AM; Loughlin KR
J Urol; 2005 Dec; 174(6):2125-8. PubMed ID: 16280741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
